Literature DB >> 17235045

Predictors of prophylactic bilateral salpingo-oophorectomy compared with gynecologic screening use in BRCA1/2 mutation carriers.

Joanna B Madalinska1, Marc van Beurden, Eveline M A Bleiker, Heiddis B Valdimarsdottir, Lottie Lubsen-Brandsma, Leon F Massuger, Marian J E Mourits, Katja N Gaarenstroom, Eleonora B L van Dorst, Hans van der Putten, Henk Boonstra, Neil K Aaronson.   

Abstract

PURPOSE: Women with BRCA1/2 gene mutations who have completed their childbearing are strong candidates for risk-reducing prophylactic bilateral salpingo-oophorectomy (PBSO). The aim of the current study was to identify baseline predictors of PBSO versus gynecologic screening (GS) in this group of high-risk women. PATIENTS AND METHODS: Baseline questionnaires were available from 160 BRCA1/2 carriers who participated in a nationwide, longitudinal, observational study of the psychosocial consequences of prophylactic surgery versus periodic screening. Topics addressed by the questionnaire included generic quality of life, cancer-specific distress, risk perception, knowledge of ovarian cancer, and perceived pros and cons of surgery versus screening. PBSO use during the 12-month period after the first gynecologic consultation was determined on the basis of medical record data.
RESULTS: During the 12-month follow-up period, 74% of women had undergone PBSO, and 26% opted for screening. Statistically significant multivariate predictors of PBSO included education, general health perceptions, perceived incurability of ovarian cancer, and perceived benefits of surgery.
CONCLUSION: Women with lower educational levels, with poorer general health perceptions, who view ovarian cancer as an incurable disease, and who believe more strongly in the benefits of surgery are more likely to undergo PBSO. Clinicians should ensure that high-risk women are well informed about the low predictive value of GS techniques and about the lethal threat posed by ovarian cancer because of its limited curability.

Entities:  

Mesh:

Year:  2007        PMID: 17235045     DOI: 10.1200/JCO.2006.07.4922

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  23 in total

1.  Factors affecting the decision to undergo risk-reducing salpingo-oophorectomy among women with BRCA gene mutation.

Authors:  Dongwon Kim; Eunyoung Kang; Euijun Hwang; Young Sun; Yoonsun Hwang; Cha Kyong Yom; Kidong Kim; Jae Hong No; Yong-Beom Kim; Sung-Won Kim
Journal:  Fam Cancer       Date:  2013-12       Impact factor: 2.375

2.  Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.

Authors:  Se Ik Kim; Myong Cheol Lim; Dong Ock Lee; Sun-Young Kong; Sang-Soo Seo; Sokbom Kang; Eun Sook Lee; Sang-Yoon Park
Journal:  J Cancer Res Clin Oncol       Date:  2015-10-05       Impact factor: 4.553

3.  Factors associated with altered long-term well-being after prophylactic salpingo-oophorectomy among women at increased hereditary risk for breast and ovarian cancer.

Authors:  Cyril Touboul; Catherine Uzan; Jean Laurent Ichanté; Olivier Caron; Ariane Dunant; Sarah Dauchy; Sébastien Gouy; Brigitte Bressac de Paillerets; Philippe Morice; Suzette Delaloge
Journal:  Oncologist       Date:  2011-07-17

4.  Cancer risk management in Tasmanian women with BRCA1 and BRCA2 mutations.

Authors:  Stephanie Kearton; Karen Wills; Michael Bunting; Penny Blomfield; Paul A James; Jo Burke
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

5.  Clinical background and outcomes of risk-reducing salpingo-oophorectomy for hereditary breast and ovarian cancers in Japan.

Authors:  Hidetaka Nomura; Masayuki Sekine; Shiro Yokoyama; Masami Arai; Takayuki Enomoto; Nobuhiro Takeshima; Seigo Nakamura
Journal:  Int J Clin Oncol       Date:  2019-05-04       Impact factor: 3.402

6.  The process of deciding about prophylactic surgery for breast and ovarian cancer: Patient questions, uncertainties, and communication.

Authors:  Robert Klitzman; Wendy Chung
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

7.  Risk-reducing salpingo-oophorectomy and ovarian cancer screening in 1077 women after BRCA testing.

Authors:  Gabriel N Mannis; Julia E Fehniger; Jennifer S Creasman; Vanessa L Jacoby; Mary S Beattie
Journal:  JAMA Intern Med       Date:  2013-01-28       Impact factor: 21.873

8.  Understanding the needs of women considering risk-reducing salpingo-oophorectomy.

Authors:  Carol Cherry; Mary Ropka; Jennifer Lyle; Laura Napolitano; Mary B Daly
Journal:  Cancer Nurs       Date:  2013 May-Jun       Impact factor: 2.592

9.  Life trajectories, genetic testing, and risk reduction decisions in 18-39 year old women at risk for hereditary breast and ovarian cancer.

Authors:  Rebekah Hamilton; Janet K Williams; Barbara J Bowers; Kathleen Calzone
Journal:  J Genet Couns       Date:  2008-11-01       Impact factor: 2.537

Review 10.  Mathematical models of breast and ovarian cancers.

Authors:  Dana-Adriana Botesteanu; Stanley Lipkowitz; Jung-Min Lee; Doron Levy
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2016-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.